Calcitriol (1α,25-Dihydroxyvitamin D3) Ointment in Psoriasis, a Safety Tolerance and Efficacy Multicentre Study
作者:
J.M. Wishart,
期刊:
Dermatology
(Karger Available online 1994)
卷期:
Volume 188,
issue 2
页码: 135-139
ISSN:1018-8665
年代: 1994
DOI:10.1159/000247118
出版商: S. Karger AG
关键词: Calcitriol;Psoriasis;Safety;Tolerance
数据来源: Karger
摘要:
30 patients were treated with daily application of calcitriol (1α,25-dihydroxy-vitamin D3) ointment 15 μg/g in white petrolatum. The patients were divided into three groups according to the size of their total area of psoriasis. They were treated for 6 weeks, and investigated first with weekly and then with two-weekly estimations of calcium metabolism (serum calcium, 24-hour urinary calcium, parathyroid hormone, 25-hydroxyvitamin D3 and calcitriol). Ninety percent of the patients cleared or improved and there were no significant side effects or local intolerance. Cosmetic acceptance was good. No clinically significant changes in calcium metabolism were observed in spite of calcitriol application ranging between 73.98 and 306.10 μg daily (normal daily synthesis being 1–2
点击下载:
PDF
(1892KB)
返 回